On 6/28/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock enjoyed a major increase of 12.4%, closing at $5.43. Moreover, trading volume in this advance was exceptionally high at 374% of normal. The stock has been exceptionally strong relative to the market over the last nine months and has risen 20.9% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of D (Negative). With this rating, PTR's two proprietary measures of a stock's current attractiveness are providing very contradictory signals. Marker Therapeutics has a very low Appreciation Score of 5 but a good Power Rating of 75, producing the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.